CDVs are new type of nanovesicles that can function as intercellular messengers and drug transporters, similar to extracellular vesicles (EVs) such as exosomes.
Because exosomes, naturally secreted from cells, are harvested from culture medium, production is limited. In contrast, CDVs can be produced in large quantities in a rapid process through direct extrusion from various human cells.
The extrusion technology, a core proprietary technology of MDimune, is patented in five major countries (USA, Europe, China, Japan, and Korea).